ambiopharm - a global peptide cdmo revenue | AmbioPharm - A Global Peptide CDMO Revenue and Industry Evolution

AmbioPharm, a global peptide CDMO, was founded in 2005 and is headquartered in North Augusta, South Carolina, USA specializing in developing highly efficient peptide manufacturing processes for peptide-based Active Pharmaceutical Ingredients (APIs) at small to very large scales. Source (opens in a new tab)

Website

https://www.ambiopharm.com/

Headquarters

US

Provider types

CDMO, API manufacturer